✦ LIBER ✦

Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancer

✍ Scribed by Aaron Sulkes; Eliahu Gez; M. Raphael Pfeffer; Raphael Catane; Rut Isacson; Shoshana Biran

Publisher: Springer
Year: 1986
Tongue: English
Weight: 643 KB
Volume: 18
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00262288

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitomycin C and vinblastine chemotherapy

Mitomycin C and vinblastine chemotherapy for advanced breast cancer

✍ P. H. Konits; J. Aisner; D. A. Van Echo; K. Lichtenfeld; P. H. Wiernik 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 2 views

Effective second line chemotherapy of ad

Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C

✍ W. Scheithauer; G. Kornek; K. Haider; W. Kwasny; T. Schenk; R. Pirker; D. Depisc 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 459 KB

Adriamycin (doxorubicin), vinblastine, a

Adriamycin (doxorubicin), vinblastine, and mitomycin C combination chemotherapy in refractory breast carcinoma

✍ Sharon D. Luikart; Gary B. Witman; Carol S. Portlock 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views

Mitomycin-C, VP16-213 combination as thi

Mitomycin-C, VP16-213 combination as third line chemotherapy in advanced breast cancer

✍ G. Perez Manga; P. L. Madrigal Alonso; H. Alburquerque Carbuccia 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 199 KB

Vindesine and mitomycin c in chemotherap

Vindesine and mitomycin c in chemotherapy refractory advanced breast cancer

✍ Franco Di Costanzo; Stefania Gori; Maurizio Tonato; Franco Buzzi; Lucio Crino; F 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Vinblastine, adriamycin, thiotepa, and h

Vinblastine, adriamycin, thiotepa, and halotestin (VATH). Therapy for advanced breast cancer refractory to prior chemotherapy

✍ Marjorie Perloff; Ronald D. Hart; James F. Holland 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 1 views

Nineteen postmenopausal patients with metastatic breast cancer refractory to conventional combination chemotherapy were treated with monthly cycles with the combination of vinblastine, adriamycin, thiotepa and halotestin. Ten patients (52%) responded with a greater than 50% regression of measurable